Baird Reiterates Outperform on Genentech (DNA)
Tweet Send to a Friend
Robert W. Baird reiterates its Outperform rating and $85 price target on Genentech (NYSE: DNA).
The firm said it ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The firm said it ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
